Audited August 3, 2026
The claim that retatrutide helps balance blood sugar is supported by human clinical trial evidence. Phase 2 data (Jastreboff et al., NEJM 2023) and Phase 3 results (TRIUMPH-4) in human subjects document retatrutide's metabolic effects, including improved glycemic control and insulin sensitivity, confirming the mechanism described. The claim accurately reflects the direction of available clinical evidence.
Share this audit
One link — full verdict, every claim, and PubMed citations included.
Shareable link includes the full verdict, claims, and PubMed citations.
Post captionshow
when taking igf1lr3 and cjc + ipa. u should have reta on the side to balance blood sugar
Claim breakdown
1 claim“Reta (Retatrutide) helps balance blood sugar.”
Human Phase 2 clinical trial (Jastreboff et al., NEJM 2023, PMID: 37354027) demonstrates retatrutide's blood sugar-regulating effects via GLP-1/GIP/glucagon receptor agonism. Phase 3 data (TRIUMPH-4, December 2025) further confirms metabolic benefits including weight loss and improved insulin sensitivity, supporting the claim's mechanistic direction in human subjects.
Supporting studies
- 1
GIPR:GCGR co-agonism restores normal weight in obese rodents
Molecular metabolism · 2026·PMID 41997446
- 2
Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?
Diabetes care · 2024·PMID 38687506
- 3
Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials
Diabetes, obesity & metabolism · 2026·PMID 41090431
- 4
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
Lancet (London, England) · 2023·PMID 37385280
- 5
Triple Agonism Based Therapies for Obesity
Current cardiovascular risk reports · 2025·PMID 40741227
This audit is for educational purposes only. Not medical advice. Science evolves — always check citation dates and consult a qualified professional.
Report an error